| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 10162130 | Journal of Pharmaceutical Sciences | 2015 | 14 Pages | 
Abstract
												Polymorphism of crystalline drugs is a common phenomenon. However, the number of reported polymorphic cocrystals is very limited. In this work, the synthesis and solid-state characterization of a polymorphic cocrystal composed of sulfadimidine (SD) and 4-aminosalicylic acid (4-ASA) is reported for the first time. By liquid-assisted milling, the SD:4-ASA 1:1 form I cocrystal, the structure of which has been previously reported, was formed. By spray drying, a new polymorphic form (form II) of the SD:4-ASA 1:1 cocrystal was discovered which could also be obtained by solvent evaporation from ethanol and acetone. Structure determination of the form II cocrystal was calculated using high-resolution X-ray powder diffraction. The solubility of the SD:4-ASA 1:1 cocrystal was dependent on the pH and predicted by a model established for a two amphoteric component cocrystal. The form I cocrystal was found to be thermodynamically more stable in aqueous solution than form II, which showed transformation to form I. Dissolution studies revealed that the dissolution rate of SD from both cocrystals was enhanced when compared with a physical equimolar mixture and pure SD.
											Keywords
												
											Related Topics
												
													Health Sciences
													Pharmacology, Toxicology and Pharmaceutical Science
													Drug Discovery
												
											Authors
												Christine Grossjohann, Dolores R. Serrano, Krzysztof J. Paluch, Peter O'Connell, Liana Vella-Zarb, Panagiotis Manesiotis, Thomas McCabe, Lidia Tajber, Owen I. Corrigan, Anne Marie Healy, 
											